DE69625236T2 - Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten - Google Patents

Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten

Info

Publication number
DE69625236T2
DE69625236T2 DE69625236T DE69625236T DE69625236T2 DE 69625236 T2 DE69625236 T2 DE 69625236T2 DE 69625236 T DE69625236 T DE 69625236T DE 69625236 T DE69625236 T DE 69625236T DE 69625236 T2 DE69625236 T2 DE 69625236T2
Authority
DE
Germany
Prior art keywords
prostate cancer
apolipoprotein
mirror
measuring
body liquids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625236T
Other languages
English (en)
Other versions
DE69625236D1 (de
Inventor
Wayne Tilley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signet Laboratories
Original Assignee
Signet Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signet Laboratories filed Critical Signet Laboratories
Publication of DE69625236D1 publication Critical patent/DE69625236D1/de
Application granted granted Critical
Publication of DE69625236T2 publication Critical patent/DE69625236T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/803—Stabe free radicals, e.g. spin immunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE69625236T 1995-09-15 1996-09-13 Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten Expired - Lifetime DE69625236T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US387495P 1995-09-15 1995-09-15
PCT/US1996/014753 WO1997010503A1 (en) 1995-09-15 1996-09-13 Method for screening for prostate cancer by measuring apolipoprotein d levels in body fluid

Publications (2)

Publication Number Publication Date
DE69625236D1 DE69625236D1 (de) 2003-01-16
DE69625236T2 true DE69625236T2 (de) 2003-08-21

Family

ID=21708017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625236T Expired - Lifetime DE69625236T2 (de) 1995-09-15 1996-09-13 Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten

Country Status (8)

Country Link
US (1) US5804368A (de)
EP (1) EP0862739B1 (de)
JP (1) JP3564668B2 (de)
AT (1) ATE229183T1 (de)
AU (1) AU722666B2 (de)
CA (1) CA2232004C (de)
DE (1) DE69625236T2 (de)
WO (1) WO1997010503A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502227B1 (de) * 2005-08-08 2007-08-15 Vitateq Biotechnology Gmbh Verfahren zur diagnose von tumoren
ES2573954T3 (es) 2008-12-30 2016-06-13 Children's Medical Center Corporation Método de predicción de apendicitis aguda

Also Published As

Publication number Publication date
EP0862739B1 (de) 2002-12-04
DE69625236D1 (de) 2003-01-16
WO1997010503A1 (en) 1997-03-20
AU722666B2 (en) 2000-08-10
CA2232004C (en) 2007-11-06
EP0862739A4 (de) 2001-06-06
JP3564668B2 (ja) 2004-09-15
JPH11512525A (ja) 1999-10-26
ATE229183T1 (de) 2002-12-15
EP0862739A1 (de) 1998-09-09
US5804368A (en) 1998-09-08
AU6977996A (en) 1997-04-01
CA2232004A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
NO922149L (no) Fremgangsmaater for paavisning av kollagen-nedbrytning in vivo
GR3019992T3 (en) Method for improving measurement precision in evanescent wave optical biosensor assays.
ES2148225T3 (es) Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
IL74303A (en) Compositions and test device for determining the presence of leukocytes,esterase and protease in biological samples
NO890071D0 (no) Nedbrytningsanalyse for kollagen type iii.
NZ330475A (en) Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation
BR9300639A (pt) Particulas marcadoras para uso no ensaio de uma amostra de um fluido biologico,processo pra ensaiar uma amostra de fluido biologico,e,processo para ensaiar uma amostra de sangue
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
DE69625236T2 (de) Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten
DE69414871T2 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
ATE146596T1 (de) Diagnostisches verfahren und reagenz für hiv
ATE377192T1 (de) Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls
DE59300909D1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
AU2836299A (en) Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins
ATE119578T1 (de) Verfahren und reagenz zur bestimmung von antithrombin iii.
ATE125623T1 (de) Reduzierbare indikatoren, die pyrogallol enthalten und deren verwendung.
ES8502261A1 (es) Un metodo para determinar ligandos en una muestra.
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
Ishizuka et al. The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma (HCC)
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys
RU95110246A (ru) Способ определения количества куриного пепсина в молокосвертывающих препаратах
UA33566A (uk) Спосіб кількісного визначення ципрофлоксацину